Zhejiang Shengda Bio-Pharm Co., Ltd. (603079.SS)
CNY 16.08
(0.06%)
CNY 16.08
(0.06%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 727.4 Million | 738.01 Million | 789.73 Million | 867.31 Million | 519.14 Million | 492.7 Million |
| Cost of Revenue | 653.22 Million | 607.17 Million | 561.27 Million | 393.73 Million | 326.61 Million | 327.4 Million |
| Gross Profit | 74.18 Million | 130.84 Million | 228.46 Million | 473.57 Million | 192.52 Million | 165.3 Million |
| Operating Expenses | 119.2 Million | 108.64 Million | 152.25 Million | 192.21 Million | 121.57 Million | 106.91 Million |
| Selling, General and Administrative Expenses | 29.35 Million | 27.28 Million | 47.36 Million | 82.26 Million | 44.13 Million | 37.12 Million |
| Research and Development Expenses | 42.92 Million | 37.41 Million | 39.64 Million | 35.68 Million | 27.9 Million | 21.38 Million |
| Other Expenses | -324.67 Thousand | 43.94 Million | 65.24 Million | 74.27 Million | 49.53 Million | 1.07 Million |
| Cost and Expenses | 773.08 Million | 715.81 Million | 713.53 Million | 585.95 Million | 448.19 Million | 434.31 Million |
| Operating Income | -45.67 Million | 59.41 Million | 81.44 Million | 247.3 Million | 76.71 Million | 52.29 Million |
| Interest Expense | 1.83 Million | 4.55 Million | 5.75 Million | 4.64 Million | 11.06 Million | 6.22 Million |
| Income Tax Expense | 8.89 Million | 6.08 Million | 8.21 Million | 33.7 Million | 11.41 Million | 9.81 Million |
| Earnings before Tax | -45.3 Million | 36.52 Million | 80.04 Million | 223.67 Million | 49.17 Million | 52.39 Million |
| Net Income | -54.06 Million | 31.48 Million | 75.75 Million | 197.43 Million | 47.03 Million | 44.54 Million |
| Earnings Per Share Basic | -0.32 | 0.18 | 0.44 | 1.17 | 0.30 | 0.29 |
| Earnings Per Share Diluted | -0.32 | 0.18 | 0.44 | 1.17 | 0.30 | 0.29 |
| Weighted Average Shares Outstanding | 168.94 Million | 171.18 Million | 171.18 Million | 168.75 Million | 156.8 Million | 155.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 168.94 Million | 171.18 Million | 171.18 Million | 168.75 Million | 156.8 Million | 155.9 Million |
| Gross Margin | 0.10 | 0.18 | 0.29 | 0.55 | 0.37 | 0.34 |
| EBIT Margin | 0.05 | 0.17 | 0.21 | 0.36 | 0.25 | 0.21 |
| Profit Margin | -0.07 | 0.04 | 0.10 | 0.23 | 0.09 | 0.09 |
| EBITDA | 34.44 Million | 114.41 Million | 163.8 Million | 302.85 Million | 111.55 Million | 92.1 Million |
| Earnings Before Tax Margin | -0.06 | 0.08 | 0.10 | 0.29 | 0.15 | 0.11 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 224.39 Million | 197.11 Million | 182.58 Million | 727.4 Million | 183.29 Million | 181.07 Million |
| Cost of Revenue | 178.35 Million | 163.34 Million | 147.71 Million | 610.95 Million | 162.39 Million | 148.56 Million |
| Gross Profit | 46.04 Million | 33.76 Million | 34.87 Million | 116.45 Million | 20.9 Million | 32.51 Million |
| Operating Expenses | 32.2 Million | 32.24 Million | 31.98 Million | 119.2 Million | 26.19 Million | 30.12 Million |
| Selling, General and Administrative Expenses | 49.14 Million | 18.75 Million | 21.37 Million | - | -33.68 Million | 48.92 Million |
| Research and Development Expenses | 10.21 Million | 10.29 Million | 7.89 Million | - | 12.73 Million | 8.97 Million |
| Other Expenses | -27.15 Million | -3.2 Million | -2.71 Million | 368.25 Thousand | 1.44 Million | -280.3 Thousand |
| Cost and Expenses | 210.55 Million | 195.58 Million | 179.69 Million | 730.15 Million | 188.58 Million | 178.68 Million |
| Operating Income | 10.87 Million | 1.52 Million | 2.88 Million | -45.67 Million | -51.81 Million | 5.28 Million |
| Interest Expense | 251.78 Thousand | 274.55 Thousand | 573.61 Thousand | 1.53 Million | 589.2 Thousand | 534.48 Thousand |
| Income Tax Expense | 3.08 Million | 2.44 Million | 2.26 Million | 8.89 Million | 1.2 Million | 1.58 Million |
| Earnings before Tax | 11.01 Million | 16.62 Million | 7.56 Million | -45.3 Million | -50.36 Million | 5 Million |
| Net Income | 5.18 Million | 12.68 Million | 3.81 Million | -54.06 Million | -50.37 Million | 2.64 Million |
| Earnings Per Share Basic | 0.03 | 0.07 | 0.02 | - | -0.41 | 0.02 |
| Earnings Per Share Diluted | 0.03 | 0.07 | 0.02 | - | -0.41 | 0.02 |
| Weighted Average Shares Outstanding | 169.31 Million | 169.31 Million | 170.46 Million | 168.94 Million | 122.61 Million | 170.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 169.31 Million | 169.31 Million | 170.46 Million | 168.94 Million | 122.61 Million | 170.65 Million |
| Gross Margin | 0.21 | 0.17 | 0.19 | 0.16 | 0.11 | 0.18 |
| EBIT Margin | 0.05 | 0.11 | 0.06 | - | -0.01 | 0.02 |
| Profit Margin | 0.02 | 0.06 | 0.02 | -0.07 | -0.27 | 0.01 |
| EBITDA | 11.26 Million | 20.95 Million | 11.7 Million | - | -1.63 Million | 4.52 Million |
| Earnings Before Tax Margin | 0.05 | 0.01 | 0.02 | -0.06 | -0.28 | 0.03 |
1438
206650
BFAM
GASS
7774
KNG